Hark Capital provides $50 million NAV facility to Pharos Capital Group

On September 11, 2025, Hark Capital announced the closing of a $50 million net asset value (NAV) facility with Pharos IV-A, L.P., a middle-market private equity fund dedicated to enhancing the healthcare sector. Pharos Capital Group focuses on companies that aim to improve patient care experiences, expand access to underserved communities, and reduce healthcare costs. The capital from this facility will bolster both new and existing investments within Pharos’ healthcare portfolio.

This venture marks the third financing partnership between Hark Capital and Pharos Capital Group, reflecting Hark’s dedication to supporting resilient middle-market enterprises. Rafael Castro, Partner at Hark Capital, expressed enthusiasm about the collaboration, highlighting the significance of advancing healthcare solutions through high-impact investments. Similarly, Joel Goldberg, Partner at Pharos, emphasized the value of Hark's flexible financing solutions that align with their goal of creating better healthcare access and outcomes.

The NAV facility capitalizes on the credit strength and diversity of the Pharos IV-A portfolio while enabling Hark Capital to showcase its expertise in innovative fund finance solutions tailored for middle-market sponsors. Hark Capital has established itself as a leader in the NAV lending space since its inception in 2013, having deployed over $1.7 billion across more than 130 transactions with upwards of 60 sponsors globally.

Pharos Capital Group, meanwhile, founded by healthcare professionals, has solidified its presence in the investment landscape by focusing on companies that prioritize reducing care costs and improving patient outcomes. With over $900 million in private equity assets managed by mid-2025 and significant investments in over 60 companies, Pharos is well-positioned for continued growth within the healthcare sector.

The recent announcement of Hark Capital providing a $50 million Net Asset Value (NAV) facility to Pharos Capital Group underscores a robust partnership in the burgeoning healthcare private equity sector. Investors should view this development as an indicator of resilience and strategic foresight within the middle-market space.

Hark Capital's commitment to NAV-based financing solutions highlights a growing trend where private equity firms leverage their asset portfolios to secure flexible funding. This facility not only reinforces Pharos’s existing healthcare investments but also positions it to explore new opportunities aimed at enhancing patient care and access—critical factors in today's evolving healthcare landscape. As the healthcare sector continues its shift towards value-based care, firms like Pharos, with a strong focus on outcomes and cost reduction, are likely to see heightened interest from investors.

For potential investors, this partnership is indicative of a few key market insights:

1. **Focus on Healthcare**: The health sector remains resilient amidst macroeconomic fluctuations, making it a compelling investment focus. The ongoing demand for healthcare services emphasizes the sound choice of allocating capital towards underserved areas.

2. **Middle-Market Potential**: The middle-market segment is often overlooked but presents significant growth potential. Hark’s innovative financing models cater to this niche, suggesting an opportune moment for investors to explore middle-market private equity besides traditional large-cap options.

3. **Strategic Alignment**: Hark's approach of supporting firms like Pharos that have clear, socially impactful missions adds a layer of appeal to socially conscious investors looking for both financial returns and meaningful outcomes.

In conclusion, tracking the developments between Hark Capital and Pharos Capital Group could provide valuable insights into broader market trends within healthcare and private equity, making it a noteworthy consideration for investment strategies.